Fairfax et al. analyzed single-cell transcriptome sequencing and TCR-seq data from peripheral blood mononuclear cells from 55 melanoma patients before and after anti-PD-1 alone or in combination with anti-CTLA-4. This evidence concerns the gene CTLA4 and melanoma.